By Hand Delivery September 14, 2012 Lewis H. Bender Re: Separation AgreementLetter Agreement • September 20th, 2012 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Massachusetts
The purpose of this letter agreement (the “Agreement”) is to set forth the terms of your separation from Interleukin Genetics, Inc. (“Interleukin” or the “Company”). Payment of the Separation Benefit described below is contingent on your agreement to and compliance with the terms of this Agreement, as set forth below.
